cGMP HEPES, MOPS & MES Available With Full Traceability & Secure Supply Chain

BioSpectra recently announced its cGMP, US-manufactured Zwitterionic Buffers are produced in its new FDA-registered facility in Bangor, PA. These buffers include HEPES, MOPS, and MES, which are suitable for end use as an excipient in drug products. BioSpectra’s entire product line of buffers is offered with recognized or custom specifications and supported by necessary compliance. Each product is backed by a fully traceable, transparent, and secure supply chain, making it the highest quality ingredient for a variety of biopharmaceutical formulations.

“We are very proud to announce BioSpectra’s newest Zwitterionic Buffers, including HEPES, MOPS, and MES, from our new FDA-registered facility in Bangor, PA,” said Richard Mutchler, President of BioSpectra. “We continue to manufacture and provide the highest quality materials available to the biopharmaceutical industry.”

BioSpectra’s Zwitterionic buffers are ICH Q7-compliant excipients, available in high-purity crystal or solution forms. Offered in a full range of packaging sizes, BioSpectra’s buffers are endotoxin-tested, particulate-free, and bioprocess ready. By providing a low molecular weight in combination with low reactivity, they maintain a stable environment for the end product into which they are formulated. These Zwitterionic buffers offer low UV absorptivity, minimal reactivity, stable pH, and high solubility in water for use in various biological applications.

BioSpectra is a FDA-registered cGMP-compliant contract manufacturer and commercial producer of amino acids, biological buffers, carbohydrates, pharmaceutical excipients, and active pharmaceutical ingredients. BioSpectra manufactures products for the biopharmaceutical industry in its state-of-the-art Pennsylvania facilities. Excipients offered by BioSpectra are produced in accordance with cGMP guidelines to provide the highest quality materials available to the biopharmaceutical industry. For more information, visit